(Q45878377)

17 December 2017

editorial

0 references

title

Gene therapy for antiangiogenesis (English)

1 reference

17 December 2017

0 references

Kleinman HK

1

1 reference

17 December 2017

Liau G

series ordinal

2

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

17 December 2017

Journal of the National Cancer Institute

published in

1 reference

17 December 2017

volume

93

1 reference

17 December 2017

issue

13

1 reference

17 December 2017

page(s)

965-967

1 reference

17 December 2017

Endogenous angiogenesis inhibitors and their therapeutic implications

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Role of the tumor microenvironment in mediating response to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Open day review: bridging the gap between academia and industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

Gene therapy. The best of times, the worst of times

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.13.965

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.13.965

1 reference

17 December 2017

1 reference

17 December 2017